US (PA): Growing, processing operations receive full certifications

FarmaceuticalRX has received full certification to operate its grower/processor operations in Pennsylvania. FarmaceuticalRX was awarded a Grower/Processor license last summer from the Pennsylvania Medical Marijuana Office as part of Round Two of the Medical Marijuana Program. "FarmaceuticalRX's grower/processor facility, located in Farrell, Penn., is a state-of-the-art facility designed to develop high-quality medical cannabis products for patients in Pennsylvania," the team with the company says. "The company commenced harvesting in August and projects that it will commence medical product sales in Pennsylvania in the coming weeks."

"We are excited to be the first grower/processor to be fully certified to operate in Pennsylvania in Round 2," stated Rebecca Myers, founder and CEO of FarmaceuticalRX. "Our living soil cultivation, extraction and high-quality focused product development platform is growing rapidly and Pennsylvania is a core component of our multi-state operations. We will differentiate ourselves in the market with our living soil style of cultivation, our development of high quality therapeutics that include our inhouse derived terpenes and with the development of our leading brands."

FarmaceuticalRX is the first Phase II Grower/Processor to be fully certified to operate in Pennsylvania.

FarmaceuticalRX is focused on advancing the knowledge base around medical marijuana therapies. The company's formulation and branding engine is powered by multiple R&D relationships with premier academic centers held by its sister company. FarmaceuticalRX is committed to offering the highest-quality products to patients in the Pennsylvania market.

For more information:
660 Martin Luther King Jr Blvd
Farrell, PA 16121

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.